Scarica l'app Stockscreener
25.69
0.39%
0.1732
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AMPH Giù?
Forum
Previsione
Precedente Chiudi:
$25.52
Aprire:
$25.76
Volume 24 ore:
66,460
Relative Volume:
0.11
Capitalizzazione di mercato:
$1.21B
Reddito:
$723.55M
Utile/perdita netta:
$157.72M
Rapporto P/E:
8.5644
EPS:
3
Flusso di cassa netto:
$170.15M
1 W Prestazione:
-0.35%
1M Prestazione:
+7.33%
6M Prestazione:
-41.51%
1 anno Prestazione:
-37.44%
Intervallo 1D:
$25.52
$25.95
Intervallo di 1 settimana:
$25.13
$26.57
Portata 52W:
$22.64
$53.95
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
Nome
Amphastar Pharmaceuticals Inc
Settore
Telefono
909-980-9484
Indirizzo
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
Confronta AMPH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AMPH
Amphastar Pharmaceuticals Inc
|
25.68 | 1.21B | 723.55M | 157.72M | 170.15M | 3.00 |
|
HLN
Haleon Plc Adr
|
11.13 | 50.98B | 14.35B | 1.85B | 0 | 0.4023 |
|
ZTS
Zoetis Inc
|
170.41 | 74.41B | 9.29B | 2.52B | 2.28B | 5.57 |
|
RDHL
Redhill Biopharma Ltd Adr
|
1.9299 | 4.03M | 35.75M | 11.57M | -26.25M | -3.8069 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.96 | 46.23B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.48 | 20.10B | 16.54B | -1.64B | 749.00M | -1.45 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-12 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-02-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-11-22 | Iniziato | Wells Fargo | Equal Weight |
| 2024-03-05 | Iniziato | JP Morgan | Overweight |
| 2023-11-17 | Iniziato | BofA Securities | Neutral |
| 2023-07-25 | Ripresa | Jefferies | Buy |
| 2022-10-21 | Ripresa | Jefferies | Buy |
| 2022-07-29 | Iniziato | CapitalOne | Overweight |
| 2022-01-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-01-08 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-10-05 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2020-05-01 | Iniziato | Northland Capital | Outperform |
| 2019-03-13 | Downgrade | Needham | Buy → Hold |
| 2019-03-13 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2018-08-10 | Reiterato | Needham | Buy |
| 2018-03-13 | Reiterato | Needham | Buy |
| 2017-12-01 | Reiterato | Needham | Buy |
| 2017-11-09 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2017-09-27 | Reiterato | Needham | Buy |
| 2017-03-14 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2016-08-09 | Reiterato | Needham | Buy |
| 2016-05-10 | Reiterato | Needham | Buy |
| 2016-02-19 | Iniziato | Wells Fargo | Outperform |
| 2015-06-19 | Reiterato | Needham | Buy |
| 2015-06-03 | Iniziato | Raymond James | Strong Buy |
| 2014-07-21 | Iniziato | Needham | Buy |
Mostra tutto
Amphastar Pharmaceuticals Inc Borsa (AMPH) Ultime notizie
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Director Sells $12,835.00 in Stock - MarketBeat
Short Interest in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Grows By 24.9% - MarketBeat
Amphastar Pharmaceuticals director sells $12,835 in stock - Investing.com Australia
Amphastar at Jefferies Conference: Strategic Focus on Growth - Investing.com Australia
Global Antidote Market to Cross the USD 4 Billion Mark by 2032 | DelveInsight - GlobeNewswire Inc.
Amphastar Pharmaceuticals director sells $12,835 in stock By Investing.com - Investing.com South Africa
Amphastar Pharmaceuticals Stockholders Approve Key Amendments - TipRanks
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Short Interest Up 24.9% in May - Defense World
Squarepoint Ops LLC Grows Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Nuveen Asset Management LLC Sells 112,307 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Nuveen Asset Management LLC Has $3.55 Million Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar price target lowered to $35 from $40 at Wells Fargo - MSN
Two Sigma Advisers LP Sells 12,400 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
(AMPH) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Man Group plc Buys New Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Bought by Voloridge Investment Management LLC - MarketBeat
Deutsche Bank AG Buys 10,839 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Point72 Asset Management L.P. Sells 29,617 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Evolent Health, Amphastar Pharmaceuticals, Iridium, and Magnite Stocks Trade Up, What You Need To Know - Yahoo Finance
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Acquires 792 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Deutsche Bank AG Has $1.27 Million Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Twinbeech Capital LP Invests $1.74 Million in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Ameriprise Financial Inc. Grows Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by BNP Paribas Financial Markets - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Bought by Janus Henderson Group PLC - MarketBeat
246,348 Shares in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Acquired by Systematic Financial Management LP - MarketBeat
D. E. Shaw & Co. Inc. Boosts Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Generic Pharmaceuticals Stocks Q1 In Review: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs Peers - FinancialContent
Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference - ACCESS Newswire
Amphastar CFO to Lead Fireside Chat at Jefferies Global Healthcare Conference June 5 - Stock Titan
When the Price of (AMPH) Talks, People Listen - news.stocktradersdaily.com
BNP Paribas Financial Markets Sells 57,502 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Northern Trust Corp Acquires 29,808 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Jane Street Group LLC Raises Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals' (AMPH) "Neutral" Rating Reaffirmed at JPMorgan Chase & Co. - MarketBeat
Comerica Bank Cuts Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by The Manufacturers Life Insurance Company - Defense World
Amphastar Pharmaceuticals (NASDAQ:AMPH) Given “Neutral” Rating at JPMorgan Chase & Co. - Defense World
Amphastar outlines key launches and product growth drivers for 2025 - MSN
Amphastar Pharma (AMPH) Downgraded by JP Morgan with Revised Pri - GuruFocus
This Target Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday - Benzinga
Amphastar stock rating cut to Neutral by JPMorgan - Investing.com Canada
JPMorgan Downgrades Amphastar Pharmaceuticals to Neutral From Overweight, Adjusts Price Target to $30 From $45 - marketscreener.com
Amphastar (AMPH) Faces Downgrade Amid Pipeline Challenges | AMPH Stock News - GuruFocus
Amphastar Pharmaceuticals Inc Azioni (AMPH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.77%
0.45%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):